Company · CIK 1652724

# Lucira Health, Inc.

| CIK | [1652724](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001652724) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-03-31 |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-252164 | IPO Final prospectus | 2021-01-15 | 2021-02-08 | 4 |

## Filings

 5

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2021-02-08 | [424B4](https://www.sec.gov/Archives/edgar/data/1652724/000119312521031881/0001193125-21-031881-index.htm) Final prospectus | 333-252164 | 0001193125-21-031881 |
| 2021-02-04 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1652724/999999999521000444/9999999995-21-000444-index.htm) Declared effective | 333-252164 | 9999999995-21-000444 |
| 2021-02-01 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1652724/000119312521023778/0001193125-21-023778-index.htm) Amendment | 333-252164 | 0001193125-21-023778 |
| 2021-01-15 | [S-1](https://www.sec.gov/Archives/edgar/data/1652724/000119312521010174/0001193125-21-010174-index.htm) Registration filed | 333-252164 | 0001193125-21-010174 |
| 2020-11-23 | [DRS](https://www.sec.gov/Archives/edgar/data/1652724/000095012320012335/0000950123-20-012335-index.htm) Draft made public | 377-03812 | 0000950123-20-012335 |

[All filings of this company](https://equitycapital.markets/filings?cik=1652724) · [CSV](https://equitycapital.markets/filings.csv?cik=1652724)

---
Source page: https://equitycapital.markets/company/1652724 · Data: U.S. SEC EDGAR · CC BY 4.0